(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIPOVITAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIPOVITAN

ST13

US500000073378425

Class

5

Filing

73378425

Registration

1280437

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

08/05/2024

Trademark type

Word

Nice classes

5

Filing date

08/05/1982

Registration date

06/05/1984

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/05/2024

Last transaction

08/05/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

03/31/1962

First use in commerce

01/09/1982

Drawing code

1

Owner type

03

Owner location

TOSHIMA-KU, JP

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TAISHO PHARMACEUTICAL CO., LTD.
TAISHO PHARMACEUTICAL CO., LTD.

Representatives

Victoria Friedman Dennemeyer & Associates, LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

LIQUID VITAMINS

Publications

History of USPTO decisions and trademark events.

30 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/05/2024

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

08/05/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/05/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/05/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

05/15/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/05/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/18/2014

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

04/18/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/18/2014

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

04/16/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

04/16/2014

CFIT

CASE FILE IN TICRS

03/23/2011

CFIT

CASE FILE IN TICRS

03/22/2011

CFIT

CASE FILE IN TICRS

03/07/2011

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/13/2005

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/14/2004

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/14/2004

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

06/10/2004

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/19/1989

XXXX

POST REGISTRATION ACTION CORRECTION

07/20/1989

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

08/21/1986

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

03/18/1986

R.PR

REGISTERED-PRINCIPAL REGISTER

06/05/1984

PUBO

PUBLISHED FOR OPPOSITION

03/13/1984

NPUB

NOTICE OF PUBLICATION

01/26/1984

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/23/1983

CNEA

EXAMINERS AMENDMENT MAILED

12/21/1983

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/14/1983

CNRT

NON-FINAL ACTION MAILED

05/12/1983

DOCK

ASSIGNED TO EXAMINER

05/02/1983

Continuous trademark protection

Get notified about every new filing that threatens LIPOVITAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.